October 5, 2021
RegMed Investors’ (RMi) pre-open: mini bounce after two (2) October trounces
October 4, 2021
RegMed Investors’ (RMi) pre-open: October’s first full trading week looks weak
October 1, 2021
RegMed Investors’ (RMi) pre-open: same old volatility tags the sector
September 30, 2021
RegMed Investors’ (RMi) pre-open: a finger in sentiment’s dike could stem the low volume downside flow
September 29, 2021
RegMed Investors’ (RMi) pre-open: a liquid situation
September 28, 2021
RegMed Investors’ (RMi) pre-open: sector rotation?
September 27, 2021
RegMed Investors’ (RMi) pre-open: Q3’s end is coming Thursday
September 24, 2021
RegMed Investors’ (RMi) pre-open: the tide is turning
September 23, 2021
RegMed Investors’ (RMi) pre-open: I have a foreboding feeling coming
September 22, 2021
RegMed Investors’ (RMi) pre-open: consternation versus constipation
September 21, 2021
RegMed Investors’ (RMi) pre-open: the bounce back is here while fear is still on the back burner
September 20, 2021
RegMed Investors’ (RMi) pre-open: the battle for sentiment lost
September 17, 2021
RegMed Investors’ (RMi) pre-open: warned yesterday, caution today
September 16, 2021
RegMed Investors’ (RMi) pre-open: exit early, meaning today
September 15, 2021
RegMed Investors’ (RMi) pre-open: after six (6) negative of the last ten (10) sessions – a few buy maybes but, be cautionary and selective in moves
September 14, 2021
RegMed Investors’ (RMi) pre-open: the remaining Q3 cycle, treading water
September 13, 2021
RegMed Investors’ (RMi) pre-open: the stem, cell and gene therapy sector’s still vulnerable
September 10, 2021
RegMed Investors’ (RMi) pre-open: following the bouncing share pricing
September 9, 2021
RegMed Investors’ (RMi) pre-open: Slugging it out in another session
September 8, 2021
RegMed Investors’ (RMi) pre-open: more volatility and some bounces
September 7, 2021
RegMed Investors’ (RMi) pre-open: through looking glass, what does one see?
September 6, 2021
Happy Labor Day …
September 3, 2021
RegMed Investors’ (RMi) pre-open: forward momentum but, is no clinical news good or bad
September 2, 2021
RegMed Investors’ (RMi) pre-open: low volume sets the pace of the upside
September 1, 2021
RegMed Investors’ (RMi) pre-open: A risk-on environment although sentiment remains weak, following in the market not leading for the sector
2 hours 52 min ago
RMi Pre-opening: Recoil, ricochet with a cold shiver
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.